Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.65 USD | +17.86% | 0.00% | +9.27% |
05-08 | Transcript : Orexo AB, Q1 2024 Earnings Call, May 08, 2024 | |
04-17 | Orexo Expands, Extends US Patent for Nasal Anaphylaxis Treatment | MT |
Performance
1 day | +17.86% | ||
Current month | +17.86% | ||
1 month | +14.58% | ||
3 months | +11.11% | ||
6 months | +17.02% | ||
Current year | +9.27% | ||
1 year | +69.75% | ||
3 years | -66.05% | ||
5 years | -77.55% | ||
10 years | -90.98% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Specialty & Advanced Pharmaceuticals
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
+17.86% | 0.00% | +9.27% | +69.75% | 68.05M | ||
+0.23% | -1.98% | +10.49% | -4.85% | 8.96B | ||
0.00% | -0.22% | -10.76% | +26.02% | 5.19B | ||
-1.31% | -4.54% | +51.58% | +92.98% | 4.77B | ||
+4.59% | +8.10% | +12.50% | +40.85% | 4.26B | ||
+0.91% | -4.58% | -20.70% | -39.28% | 2.37B | ||
-0.30% | -7.51% | +12.24% | -11.39% | 2.3B | ||
+1.02% | -4.77% | -29.65% | -45.26% | 2.21B | ||
-4.41% | +0.17% | +19.51% | -5.87% | 2.17B | ||
-.--% | -.--% | - | - | 1.64B | ||
-0.21% | +0.48% | +0.55% | -17.54% | 1.6B | ||
+0.63% | -5.68% | +2.05% | -3.66% | 1.26B | ||
-1.17% | -3.93% | -19.18% | -29.66% | 1.04B | ||
+6.15% | +13.30% | +42.30% | +35.54% | 926M | ||
0.00% | +0.96% | +2.27% | +7.37% | 899M | ||
+4.51% | +2.00% | -1.92% | +41.93% | 841M | ||
Average | +1.78% | -0.64% | +5.37% | +10.46% | ||
Weighted average by Cap. | +0.48% | -1.10% | +8.16% | +12.68% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | +9.27% | ||
2023 | -12.72% | ||
2022 | -56.86% | ||
2021 | -25.74% | ||
2020 | -18.18% | ||
2019 | +5.60% | ||
2018 | +41.40% | ||
2017 | +6.51% | ||
2016 | -40.71% | ||
2015 | -65.52% | ||
2014 | -20.39% | ||
2013 | +2.86% |
- Stock Market
- Equities
- ORX Stock
- ORXOY Stock
- Quotes Orexo AB